Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
about
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity.Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.Are drug-coated balloons cost effective for femoropopliteal occlusive disease? A comparison of bare metal stents and uncoated balloons.Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.Superficial Femoral Artery Intervention: Creating an Algorithmic Approach for the Use of Old and Novel (Endovascular) Technologies.Endovascular Management of Right Subclavian Artery Pseudoaneurysm due to War Injury in Adolescent Patient.
P2860
Q37225231-CF25B4D7-3AF3-4926-860E-0C9F496BCECBQ37463102-0FD7CB51-FC4E-45DF-A3EB-36DEF390ADB4Q38211926-5158831D-1A61-4B82-B75F-451313D73AE2Q38863388-CC26F345-DE15-46BF-914B-267B628084B1Q38901942-47A6C1AC-2453-413A-8A53-56795DF1474FQ38975104-7B99E33B-12B9-4D22-B2FC-56B40B8AEF1EQ42728556-ECE8E510-8563-439C-9CFC-33D4A0B40326
P2860
Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors for clinical fail ...... ropopliteal occlusive disease.
@en
type
label
Risk factors for clinical fail ...... ropopliteal occlusive disease.
@en
prefLabel
Risk factors for clinical fail ...... ropopliteal occlusive disease.
@en
P2093
P1476
Risk factors for clinical fail ...... ropopliteal occlusive disease.
@en
P2093
Charles M Eichler
Christopher D Owens
Darren B Schneider
Jade S Hiramoto
Michael S Conte
Paul C Johnston
Sara J Runge
Shant M Vartanian
P304
998-1006, 1007.e1; discussion 1006-7
P356
10.1016/J.JVS.2012.03.010
P577
2012-05-25T00:00:00Z